5Talalaj J,Kowal E.Level of D-dimer and comparison with cell count in pleural effusion from tubercnlosis and neoplasms[J].Pneumonol Alergol Pol,1996,64:431-436.
6Philip JF,Slessi MC,Philip JC,et al.Fibrinolytic and in flammatorg processes in pleural effusions[J].EurRespir J,1995,8:1352-1356.
1Rosen H, Nadkarni V,Theroux M,et al Intrapleural streptokinase as adjunctive treatment for persispent empyema in pediatric patients [J].Chest,1993;103:1190～1193.
2Bouros D, Schiza S, Patsourakis G, et al Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusion [J]. Am J Respir Crit Care Med,1997,155:294～295.
3Pollack J S, Passik C S. Intrapleural urokinase in the treatment of loculated pleural effusions [J]. Chest, 1994,105;868～873.
4穆魁津，胸膜疾病，1994年，97页
5Lee K S，Radiology，1991年，179卷，771页
6Light RW. Pleural effusion. N Engl J Med 2002,346(25):1971～1977.
7Romero-Candeira S, Hernandez L, Romero-Brufao S et al. Is It Meaningful To Use BiochemicalParameters To Discriminate Between Transudative and Exudative Pleural Effusions? Chest.2002; 122:1524～ 1529.
8Aoe K,Hiraki A,Murakami T,et al. Diagnostic significance of Interferon-γ in tuberculous pleural effusions. Chest 2003, 123:740～744.
9Putnam, JB Jr. Malignant Pleural Effusions. Surgical Clinics of North America 2002;82(4) :867～883.
